How I could make £1 million investing in an ISA

This writer sets out a realistic strategy and timeframe for getting to a seven-figure ISA portfolio by investing in the stock market.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Reaching a million pounds in a Stocks and Shares ISA isn’t as far-fetched as it sounds. According to the latest data available, there were nearly 5,000 ISA millionaires in the UK!

However, those figures were from over 18 months ago. Here’s what the stock market has done since then:

  • FTSE All-World Index: +33%
  • S&P 500: +48%
  • Nasdaq: +64%
  • FTSE 100 +8%
  • FTSE 250: +12%

These returns don’t even include dividends. Therefore, I assume there’ll be well over 5,000 investors with a seven-figure portfolio right now. We’ll know for sure when the next set of figures is released.

Should you invest £1,000 in Taylor Wimpey right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Taylor Wimpey made the list?

See the 6 stocks

Here, I’ll outline how I aim to one day join this growing ISA millionaire club by investing quite modest sums.

Active investing

My first goal is to try and max out the annual ISA allowance, which currently stands at £20,000. This works out at approximately £1,666 a month or £384 a week.

Next, I aim to beat the market by picking individual stocks (active investing). My portfolio is globally diversified, including many UK and US shares, so I think the FTSE All-World Index is a good benchmark.

It’s comprised of about 3,645 large and mid-sized company stocks in developed and emerging markets.

The average annual return of this index is around 10.3%. I’m targeting a return slightly above this over time (roughly 12%).

A potential hidden gem

One under-the-radar stock I’ve been considering for my portfolio is Novocure (NASDAQ: NVCR). This is a global oncology company that has pioneered Tumour Treating Fields (TTFields) therapy.

This involves the use of electric fields to disrupt cancer cell division, while sparing healthy cells. Its flagship product is Optune, a scalp-worn, portable device approved for an aggressive form of brain cancer.

In Q3, the firm’s revenue grew 22% year on year to $155m. However, its net loss was $30.6m, due to $51.9m in research, development, and clinical studies expenses.

Though I expect the firm to reach profitability, these losses add risk, despite it also having $960m in cash.

On 2 December, the firm announced that its TTFields therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy.

This was Novocure’s third positive Phase 3 clinical trial in the last two years. And upon this news, the stock exploded nearly 50% higher. However, it still remains 87% below its mid-2021 record.

Novocure will probably file for regulatory approval of this new cancer product in 2025, with its Chinese partner, Zai Lab, doing likewise in China.

From today’s modest $2.9bn market cap, I think the stock could outperform long term. I’m seriously considering it.

Created with Highcharts 11.4.3NovoCure PriceZoom1M3M6MYTD1Y5Y10YALL7 Dec 20197 Dec 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '242020202020212021202220222023202320242024www.fool.co.uk

Getting to £1m

So, I have my amount (£1,666 a month) and the average return target (12%). Now I can calculate how long it should take my ISA to reach seven figures.

Note that I haven’t included platform fees, and the figures assume I reinvest dividends to really fuel compound returns. Naturally, it’s possible I might underperform, and individual dividends aren’t guaranteed.

YearAccrued interestBalance
1£1,099£21,091
5£34,031£133,991
10£170,210£370,130
15£486,407£786,287
17£691,168£1,031,032

In the above scenario, it’ll take me just under 17 years to reach £1m. Due to the power of compounding though, it’d only take another six years of regular investing to get to £2m!

Food for thought…

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our best passive income stock ideas

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

More on Investing Articles

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Dividend Shares

2 ‘safe’ LSE dividend stocks to consider as global markets sell off

As global markets experience high levels of volatility due to economic uncertainty, investors are piling into these ‘safe-haven’ dividend stocks.

Read more »

Investing Articles

US stock market rout: an unmissable opportunity for investors?

His tech-heavy portfolio has been smashed by Trump’s tariffs. However, Dr James Fox believes there could be some opportunities in…

Read more »

Investing Articles

After a 13% ‘Trump tariff’ fall, is the Barclays share price too cheap to miss?

Does the Barclays share price fall mean we should all panic and run screaming from the stock market? Nah, of…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

2 investment trusts to consider for a Stocks and Shares ISA

These two investment trusts have a different focus -- but our writer sees both as worth considering, one more for…

Read more »

Investing Articles

Deutsche Bank reiterates Buy rating on 9.6% yielding FTSE 250 stock that was “most shorted in UK”

Our writer investigates why a major broker remains optimistic about a FTSE 250 stock that was once the most shorted…

Read more »

Investing Articles

2 things to remember when stock markets are turbulent

US trade policy has rattled the stock markets in New York, London and elsewhere. Our writer outlines a couple of…

Read more »

Investing Articles

Are Trump’s tariffs a once-in-a-lifetime chance for ISA investors to get rich?

The £20,000 Stocks and Shares ISA limit will reset on 6 April. Smart investors could use current market volatility to…

Read more »

Investing Articles

Here are the latest Persimmon share price and dividend forecasts

Our writer looks at the latest forecasts for the Persimmon share price and considers what level of dividend the stock…

Read more »